Biopharmaceutical Third-Party Logistics Market Regional Analysis:
North America Market Insights
North America industry is set to account for largest revenue share of 42.3% by 2035, owing to several driving forces as the region has a vast and rapidly evolving biopharmaceutical industry, characterized by a strong presence of biotech companies, research institutions, and manufacturing facilities that have created strong demand for specialized logistics services. The region has well-structured and established transport infrastructure such as airports, seaports, and highways which ensures efficient and safe transportation of biopharmaceutical products.
North America is governed by a strict regulatory environment heavily dominated by authorized which has led to logistics providers making the necessary investment in compliant and secure solutions hence supporting the growth of the market. The strong economic growth in this region, coupled with the growing investments in the research and development of biopharmaceuticals, and the trend of outsourcing logistics operations by third-party specialized providers is further boosting this market.
The U.S. is the largest revenue-generating country for biopharmaceutical third-party logistics in North America. This growth is attributed to factors such as increasing demand for biopharmaceuticals, the presence of advanced healthcare systems, and the growing adoption of cutting-edge technologies such as real-time monitoring and temperature-controlled logistics. In June 2024, Alcami Corporation announced the expansion of its warehousing and storage of pharma products with the launch of a new 65,000 ft2 state-of-the-art pharma storage facility in Garner.
Asia Pacific Market Insights
Asia Pacific is expected to be the fastest-growing region in the biopharmaceutical third-party logistics market owing to rising demand for biosimilars and biopharmaceuticals to cater to the rising cases of chronic illnesses and the growing need for advanced storage and logistics solutions. Additionally, growing expenditure on healthcare and the high adoption of innovative therapies are all contributing to this market growth.
The local government strives to formulate policies that aim at developing biopharmaceuticals through several infrastructure investments, tax incentives, and streamlined regulatory procedures. Thus, the Asia Pacific continues to grow in leaps and bounds as logistics providers continue to invest in building sound infrastructure and meeting the changing needs of biopharmaceutical companies.
In India, the market is expected to witness rapid revenue growth owing to rising demand for advanced healthcare solutions, expanding pharmaceutical production, and the need for robust infrastructure for cold-chain transitions and warehousing to store specialty drugs and vaccines.
